Advertisement

Autoinflammatory Disorders

  • Stefan Berg
  • Anders Fasth
  • Autoinflammatory disorders constitutes a new term that covers a group of diseases characterized by recurrent generalized inflammation in the absence of infectious or autoimmune causes.

  • Dysregulation of the innate immune system causes inflammation by affecting the pathways connected to the NOD-like receptors.

  • The patients are at risk of developing amyloidosis, the main long-term sequelae of many of these disorders.

  • The term was initially used only for the inherited periodic fever syndromes.

  • Over the past few years, the concept of autoinflammatory disorders has expanded to encompass an increasing number of polygenic/multifactorial diseases.

Keywords

Familial Mediterranean Fever Periodic Fever Autoinflammatory Disease Chronic Recurrent Multifocal Osteomyelitis Systemic Onset Juvenile Idiopathic Arthritis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Aganna E, Martinon F, Hawkins PN, Ross JB, Swan DC, Booth DR, Lachmann HJ, Bybee A, Gaudet R, Woo P, Feighery C, Cotter FE, Thome M, Hitman GA, Tschopp J, McDermott MF (2002) Association of mutations in the NALP3/CIAS1/PYPAF1 gene with a broad phenotype including recurrent fever, cold sensitivity, sensorineural deafness, and AA amyloidosis. Arthritis Rheum 46: 2445–2452PubMedCrossRefGoogle Scholar
  2. 2.
    Aksentijevich I, C DP, Remmers EF, Mueller JL, Le J, Kolodner RD, Moak Z, Chuang M, Austin F, Goldbach-Mansky R, Hoffman HM, Kastner DL (2007) The clinical continuum of cryopyrinopathies: novel CIAS1 mutations in North American patients and a new cryopyrin model. Arthritis Rheum 56:1273–1285PubMedCrossRefGoogle Scholar
  3. 3.
    Aksentijevich I, Galon J, Soares M, Mansfield E, Hull K, Oh HH, Goldbach-Mansky R, Dean J, Athreya B, Reginato AJ, Henrickson M, Pons-Estel B, O’Shea JJ, Kastner DL (2001) The tumor-necrosis-factor receptor-associated periodic syndrome: new mutations in TNFRSF1A, ancestral origins, genotype-phenotype studies, and evidence for further genetic heterogeneity of periodic fevers. Am J Hum Genet 69:301–314PubMedCrossRefGoogle Scholar
  4. 4.
    Aksentijevich I, Nowak M, Mallah M, Chae JJ, Watford WT, Hofmann SR, Stein L, Russo R, Goldsmith D, Dent P, Rosenberg HF, Austin F, Remmers EF, Balow JE, Jr., Rosenzweig S, Komarow H, Shoham NG, Wood G, Jones J, Mangra N, Carrero H, Adams BS, Moore TL, Schikler K, Hoffman H, Lovell DJ, Lipnick R, Barron K, O’Shea JJ, Kastner DL, Goldbach-Mansky R (2002) De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases. Arthritis Rheum 46:3340–3348PubMedCrossRefGoogle Scholar
  5. 5.
    Aldea A, Calafell F, Arostegui JI, Lao O, Rius J, Plaza S, Maso M, Vives J, Buades J, Yague J (2004) The west side story: MEFV haplotype in Spanish FMF patients and controls, and evidence of high LD and a recombination “hot-spot” at the MEFV locus. Hum Mutat 23:399PubMedCrossRefGoogle Scholar
  6. 6.
    Arkwright PD, Abinun M, Cant AJ (2007) Mevalonic aciduria cured by bone marrow transplantation. N Engl J Med 357:1350PubMedCrossRefGoogle Scholar
  7. 7.
    Balci B, Tinaztepe K, Yilmaz E, Gucer S, Ozen S, Topaloglu R, Besbas N, Ozguc M, Bakkaloglu A (2002) MEFV gene mutations in familial Mediterranean fever phenotype II patients with renal amyloidosis in childhood: a retrospective clinicopathological and molecular study. Nephrol Dial Transplant 17:1921–1923PubMedCrossRefGoogle Scholar
  8. 8.
    Bergdahl K, Bjorksten B, Gustavson KH, Liden S, Probst F (1979) Pustulosis palmoplantaris and its relation to chronic recurrent multifocal osteomyelitis. Dermatologica 159:37–45PubMedCrossRefGoogle Scholar
  9. 9.
    Berkun Y, Padeh S, Reichman B, Zaks N, Rabinovich E, Lidar M, Shainberg B, Livneh A (2007) A Single Testing of Serum Amyloid A Levels as a Tool for Diagnosis and Treatment Dilemmas in Familial Mediterranean Fever. Semin Arthritis Rheum 37:182–188PubMedCrossRefGoogle Scholar
  10. 10.
    Blau EB (1985) Familial granulomatous arthritis, iritis, and rash. J Pediatr 107:689–693PubMedCrossRefGoogle Scholar
  11. 11.
    Bodar EJ, van der Hilst JC, Drenth JP, van der Meer JW, Simon A (2005) Effect of etanercept and anakinra on inflammatory attacks in the hyper-IgD syndrome: introducing a vaccination provocation model. Neth J Med 63:260–264PubMedGoogle Scholar
  12. 12.
    Cailliez M, Garaix F, Rousset-Rouviere C, Bruno D, Kone-Paut I, Sarles J, Chabrol B, Tsimaratos M (2006) Anakinra is safe and effective in controlling hyperimmunoglobulinaemia D syndrome-associated febrile crisis. J Inherit Metab Dis 29:763PubMedCrossRefGoogle Scholar
  13. 13.
    Calligaris L, Marchetti F, Tommasini A, Ventura A (2008) The efficacy of anakinra in an adolescent with colchicine-resistant familial Mediterranean fever. Eur J Pediatr 167:695–696PubMedCrossRefGoogle Scholar
  14. 14.
    Cazeneuve C, Sarkisian T, Pecheux C, Dervichian M, Nedelec B, Reinert P, Ayvazyan A, Kouyoumdjian JC, Ajrapetyan H, Delpech M, Goossens M, Dode C, Grateau G, Amselem S (1999) MEFV-Gene analysis in armenian patients with Familial Mediterranean fever: diagnostic value and unfavorable renal prognosis of the M694V homozygous genotype-genetic and therapeutic implications. Am J Hum Genet 65:88–97PubMedCrossRefGoogle Scholar
  15. 15.
    Chae JJ, Wood G, Masters SL, Richard K, Park G, Smith BJ, Kastner DL (2006) The B30.2 domain of pyrin, the familial Mediterranean fever protein, interacts directly with caspase-1 to modulate IL-1beta production. Proc Natl Acad Sci USA 103:9982–9987PubMedCrossRefGoogle Scholar
  16. 16.
    Church LD, Churchman SM, Hawkins PN, McDermott MF (2006) Hereditary auto-inflammatory disorders and biologics. Semin Immunopathol 27:494–508CrossRefGoogle Scholar
  17. 17.
    Cortis E, De Benedetti F, Insalaco A, Cioschi S, Muratori F, D’Urbano LE, Ugazio AG (2004) Abnormal production of tumor necrosis factor (TNF)–alpha and clinical efficacy of the TNF inhibitor etanercept in a patient with PAPA syndrome [corrected]. J Pediatr 145:851–855PubMedCrossRefGoogle Scholar
  18. 18.
    Cuisset L, Drenth JP, Berthelot JM, Meyrier A, Vaudour G, Watts RA, Scott DG, Nicholls A, Pavek S, Vasseur C, Beckmann JS, Delpech M, Grateau G (1999) Genetic linkage of the Muckle–Wells syndrome to chromosome 1q44. Am J Hum Genet 65:1054–1059PubMedCrossRefGoogle Scholar
  19. 19.
    Dierselhuis MP, Frenkel J, Wulffraat NM, Boelens JJ (2005) Anakinra for flares of pyogenic arthritis in PAPA syndrome. Rheumatology (Oxford) 44:406–408CrossRefGoogle Scholar
  20. 20.
    Dinarello CA, Wolff SM, Goldfinger SE, Dale DC, Alling DW (1974) Colchicine therapy for familial mediterranean fever. A double-blind trial. N Engl J Med 291:934–937PubMedGoogle Scholar
  21. 21.
    Dode C, Le Du N, Cuisset L, Letourneur F, Berthelot JM, Vaudour G, Meyrier A, Watts RA, Scott DG, Nicholls A, Granel B, Frances C, Garcier F, Edery P, Boulinguez S, Domergues JP, Delpech M, Grateau G (2002) New mutations of CIAS1 that are responsible for Muckle–Wells syndrome and familial cold urticaria: a novel mutation underlies both syndromes. Am J Hum Genet 70:1498–1506PubMedCrossRefGoogle Scholar
  22. 22.
    Drenth JP, Cuisset L, Grateau G, Vasseur C, van de Velde-Visser SD, de Jong JG, Beckmann JS, van der Meer JW, Delpech M (1999) Mutations in the gene encoding mevalonate kinase cause hyper-IgD and periodic fever syndrome. International Hyper-IgD Study Group. Nat Genet 22:178–181PubMedCrossRefGoogle Scholar
  23. 23.
    Drenth JP, Haagsma CJ, van der Meer JW (1994) Hyperimmunoglobulinemia D and periodic fever syndrome. The clinical spectrum in a series of 50 patients. International Hyper-IgD Study Group. Medicine (Baltimore) 73:133–144Google Scholar
  24. 24.
    Drewe E, McDermott EM, Powell PT, Isaacs JD, Powell RJ (2003) Prospective study of anti-tumour necrosis factor receptor superfamily 1B fusion protein, and case study of anti-tumour necrosis factor receptor superfamily 1A fusion protein, in tumour necrosis factor receptor associated periodic syndrome (TRAPS): clinical and laboratory findings in a series of seven patients. Rheumatology (Oxford) 42:235–239CrossRefGoogle Scholar
  25. 25.
    Duzova A, Bakkaloglu A, Besbas N, Topaloglu R, Ozen S, Ozaltin F, Bassoy Y, Yilmaz E (2003) Role of A-SAA in monitoring subclinical inflammation and in colchicine dosage in familial Mediterranean fever. Clin Exp Rheumatol 21:509–514PubMedGoogle Scholar
  26. 26.
    Edrees AF, Kaplan DL, Abdou NI (2002) Pyogenic arthritis, pyoderma gangrenosum, and acne syndrome (PAPA syndrome) associated with hypogammaglobulinemia and elevated serum tumor necrosis factor-alpha levels. J Clin Rheumatol 8:273–275PubMedCrossRefGoogle Scholar
  27. 27.
    El-Shanti HI, Ferguson PJ (2007) Chronic Recurrent Multifocal Osteomyelitis: A Concise Review and Genetic Update. Clin Orthop Relat Res 462:11–19PubMedCrossRefGoogle Scholar
  28. 28.
    Federici L, Rittore-Domingo C, Kone-Paut I, Jorgensen C, Rodiere M, Le Quellec A, Touitou I (2006) A decision tree for genetic diagnosis of hereditary periodic fever in unselected patients. Ann Rheum Dis 65:1427–1432PubMedCrossRefGoogle Scholar
  29. 29.
    Feldmann J, Prieur AM, Quartier P, Berquin P, Certain S, Cortis E, Teillac-Hamel D, Fischer A, de Saint Basile G (2002) Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes. Am J Hum Genet 71:198–203PubMedCrossRefGoogle Scholar
  30. 30.
    Ferguson PJ, Bing X, Vasef MA, Ochoa LA, Mahgoub A, Waldschmidt TJ, Tygrett LT, Schlueter AJ, El-Shanti H (2006) A missense mutation in pstpip2 is associated with the murine autoinflammatory disorder chronic multifocal osteomyelitis. Bone 38:41–47PubMedCrossRefGoogle Scholar
  31. 31.
    Ferguson PJ, Chen S, Tayeh MK, Ochoa L, Leal SM, Pelet A, Munnich A, Lyonnet S, Majeed HA, El-Shanti H (2005) Homozygous mutations in LPIN2 are responsible for the syndrome of chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anaemia (Majeed syndrome). J Med Genet 42:551–557PubMedCrossRefGoogle Scholar
  32. 32.
    Ferguson PJ, El-Shanti HI (2007) Autoinflammatory bone disorders. Curr Opin Rheumatol 19:492–498PubMedCrossRefGoogle Scholar
  33. 33.
    Fitzgerald AA, Leclercq SA, Yan A, Homik JE, Dinarello CA (2005) Rapid responses to anakinra in patients with refractory adult-onset Still’s disease. Arthritis Rheum 52:1794–1803PubMedCrossRefGoogle Scholar
  34. 34.
    French FMF Consortium (1997) A candidate gene for familial Mediterranean fever. Nat Genet 17:25–31CrossRefGoogle Scholar
  35. 35.
    Frenkel J, Houten SM, Waterham HR, Wanders RJ, Rijkers GT, Duran M, Kuijpers TW, van Luijk W, Poll-The BT, Kuis W (2001) Clinical and molecular variability in childhood periodic fever with hyperimmunoglobulinaemia D. Rheumatology (Oxford) 40:579–584CrossRefGoogle Scholar
  36. 36.
    Galanakis E, Papadakis CE, Giannoussi E, Karatzanis AD, Bitsori M, Helidonis ES (2002) PFAPA syndrome in children evaluated for tonsillectomy. Arch Dis Child 86:434–435PubMedCrossRefGoogle Scholar
  37. 37.
    Gattorno M, Tassi S, Carta S, Delfino L, Ferlito F, Pelagatti MA, D’Osualdo A, Buoncompagni A, Alpigiani MG, Alessio M, Martini A, Rubartelli A (2007) Pattern of interleukin-1beta secretion in response to lipopolysaccharide and ATP before and after interleukin-1 blockade in patients with CIAS1 mutations. Arthritis Rheum 56:3138–3148PubMedCrossRefGoogle Scholar
  38. 38.
    Gershoni-Baruch R, Brik R, Zacks N, Shinawi M, Lidar M, Livneh A (2003) The contribution of genotypes at the MEFV and SAA1 loci to amyloidosis and disease severity in patients with familial Mediterranean fever. Arthritis Rheum 48:1149–1155PubMedCrossRefGoogle Scholar
  39. 39.
    Goldbach-Mansky R, Dailey NJ, Canna SW, Gelabert A, Jones J, Rubin BI, Kim HJ, Brewer C, Zalewski C, Wiggs E, Hill S, Turner ML, Karp BI, Aksentijevich I, Pucino F, Penzak SR, Haverkamp MH, Stein L, Adams BS, Moore TL, Fuhlbrigge RC, Shaham B, Jarvis JN, O’Neil K, Vehe RK, Beitz LO, Gardner G, Hannan WP, Warren RW, Horn W, Cole JL, Paul SM, Hawkins PN, Pham TH, Snyder C, Wesley RA, Hoffmann SC, Holland SM, Butman JA, Kastner DL (2006) Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition. N Engl J Med 355:581–592PubMedCrossRefGoogle Scholar
  40. 40.
    Goldfinger SE (1972) Colchicine for familial Mediterranean fever. N Engl J Med 287:1302PubMedGoogle Scholar
  41. 41.
    Golla A, Jansson A, Ramser J, Hellebrand H, Zahn R, Meitinger T, Belohradsky BH, Meindl A (2002) Chronic recurrent multifocal osteomyelitis (CRMO): evidence for a susceptibility gene located on chromosome 18q21.3–18q22. Eur J Hum Genet 10:217–221PubMedCrossRefGoogle Scholar
  42. 42.
    Gul A (2005) Behcet’s disease as an autoinflammatory disorder. Curr Drug Targets Inflamm Allergy 4:81–83PubMedCrossRefGoogle Scholar
  43. 43.
    Harton JA, Linhoff MW, Zhang J, Ting JP (2002) Cutting edge: CATERPILLER: a large family of mammalian genes containing CARD, pyrin, nucleotide-binding, and leucine-rich repeat domains. J Immunol 169:4088–4093PubMedGoogle Scholar
  44. 44.
    Hassink SG, Goldsmith DP (1983) Neonatal onset multisystem inflammatory disease. Arthritis Rheum 26:668–673PubMedCrossRefGoogle Scholar
  45. 45.
    Hawkins PN, Lachmann HJ, Aganna E, McDermott MF (2004) Spectrum of clinical features in Muckle–Wells syndrome and response to anakinra. Arthritis Rheum 50:607–612PubMedCrossRefGoogle Scholar
  46. 46.
    Heller H, Sohar E, Sherf L (1958) Familial Mediterranean fever. AMA Arch Intern Med 102:50–71PubMedGoogle Scholar
  47. 47.
    Hetherington S (1982) Sarcoidosis in young children. Am J Dis Child 136:13–15PubMedGoogle Scholar
  48. 48.
    Hoffman HM, Mueller JL, Broide DH, Wanderer AA, Kolodner RD (2001) Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle–Wells syndrome. Nat Genet 29:301–305PubMedCrossRefGoogle Scholar
  49. 49.
    Hoffman HM, Rosengren S, Boyle DL, Cho JY, Nayar J, Mueller JL, Anderson JP, Wanderer AA, Firestein GS (2004) Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonist. Lancet 364:1779–1785PubMedCrossRefGoogle Scholar
  50. 50.
    Hoffman HM, Wanderer AA, Broide DH (2001) Familial cold autoinflammatory syndrome: phenotype and genotype of an autosomal dominant periodic fever. J Allergy Clin Immunol 108:615–620PubMedCrossRefGoogle Scholar
  51. 51.
    Hoffmann GF, Charpentier C, Mayatepek E, Mancini J, Leichsenring M, Gibson KM, Divry P, Hrebicek M, Lehnert W, Sartor K, et al. (1993) Clinical and biochemical phenotype in 11 patients with mevalonic aciduria. Pediatrics 91:915–921PubMedGoogle Scholar
  52. 52.
    Houten SM, Frenkel J, Rijkers GT, Wanders RJ, Kuis W, Waterham HR (2002) Temperature dependence of mutant mevalonate kinase activity as a pathogenic factor in hyper-IgD and periodic fever syndrome. Hum Mol Genet 11:3115–3124PubMedCrossRefGoogle Scholar
  53. 53.
    Houten SM, Kuis W, Duran M, de Koning TJ, van Royen-Kerkhof A, Romeijn GJ, Frenkel J, Dorland L, de Barse MM, Huijbers WA, Rijkers GT, Waterham HR, Wanders RJ, Poll-The BT (1999) Mutations in MVK, encoding mevalonate kinase, cause hyperimmunoglobulinaemia D and periodic fever syndrome. Nat Genet 22:175–177PubMedCrossRefGoogle Scholar
  54. 54.
    Huber AM, Lam PY, Duffy CM, Yeung RS, Ditchfield M, Laxer D, Cole WG, Kerr Graham H, Allen RC, Laxer RM (2002) Chronic recurrent multifocal osteomyelitis: clinical outcomes after more than five years of follow-up. J Pediatr 141:198–203PubMedCrossRefGoogle Scholar
  55. 55.
    Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J, Almer S, Tysk C, O’Morain CA, Gassull M, Binder V, Finkel Y, Cortot A, Modigliani R, Laurent-Puig P, Gower-Rousseau C, Macry J, Colombel JF, Sahbatou M, Thomas G (2001) Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease. Nature 411:599–603PubMedCrossRefGoogle Scholar
  56. 56.
    Hull KM, Drewe E, Aksentijevich I, Singh HK, Wong K, McDermott EM, Dean J, Powell RJ, Kastner DL (2002) The TNF receptor-associated periodic syndrome (TRAPS): emerging concepts of an autoinflammatory disorder. Medicine (Baltimore) 81:349–368CrossRefGoogle Scholar
  57. 57.
    Inohara N, Nunez G (2003) NODs: intracellular proteins involved in inflammation and apoptosis. Nat Rev Immunol 3:371–382PubMedCrossRefGoogle Scholar
  58. 58.
    International FMF Consortium (1997) Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. Cell 90: 797–807CrossRefGoogle Scholar
  59. 59.
    Jabs DA, Houk JL, Bias WB, Arnett FC (1985) Familial granulomatous synovitis, uveitis, and cranial neuropathies. Am J Med 78:801–804PubMedCrossRefGoogle Scholar
  60. 60.
    Jacobelli S, Andre M, Alexandra JF, Dode C, Papo T (2007) Failure of anti-TNF therapy in TNF Receptor 1-Associated Periodic Syndrome (TRAPS). Rheumatology (Oxford) 46:1211–1212CrossRefGoogle Scholar
  61. 61.
    Jansson A, Renner ED, Ramser J, Mayer A, Haban M, Meindl A, Grote V, Diebold J, Jansson V, Schneider K, Belohradsky BH (2007) Classification of non-bacterial osteitis: retrospective study of clinical, immunological and genetic aspects in 89 patients. Rheumatology (Oxford) 46:154–160CrossRefGoogle Scholar
  62. 62.
    Kallinich T, Haffner D, Niehues T, Huss K, Lainka E, Neudorf U, Schaefer C, Stojanov S, Timmann C, Keitzer R, Ozdogan H, Ozen S (2007) Colchicine use in children and adolescents with familial Mediterranean fever: literature review and consensus statement. Pediatrics 119:e474–483PubMedCrossRefGoogle Scholar
  63. 63.
    Kalliolias GD, Georgiou PE, Antonopoulos IA, Andonopoulos AP, Liossis SN (2007) Anakinra treatment in patients with adult-onset Still’s disease is fast, effective, safe and steroid sparing: experience from an uncontrolled trial. Ann Rheum Dis 66:842–843PubMedCrossRefGoogle Scholar
  64. 64.
    Kanazawa N, Matsushima S, Kambe N, Tachibana T, Nagai S, Miyachi Y (2004) Presence of a sporadic case of systemic granulomatosis syndrome with a CARD15 mutation. J Invest Dermatol 122:851–852PubMedCrossRefGoogle Scholar
  65. 65.
    Kanazawa N, Okafuji I, Kambe N, Nishikomori R, Nakata-Hizume M, Nagai S, Fuji A, Yuasa T, Manki A, Sakurai Y, Nakajima M, Kobayashi H, Fujiwara I, Tsutsumi H, Utani A, Nishigori C, Heike T, Nakahata T, Miyachi Y (2005) Early-onset sarcoidosis and CARD15 mutations with constitutive nuclear factor-kappaB activation: common genetic etiology with Blau syndrome. Blood 105:1195–1197PubMedCrossRefGoogle Scholar
  66. 66.
    Kile RL RH (1940) A case of cold urticaria with an unusual family history. JAMA 114:1067–1068Google Scholar
  67. 67.
    Kone-Paut I, Sanchez E, Le Quellec A, Manna R, Touitou I (2007) Autoinflammatory gene mutations in Behcet’s disease. Ann Rheum Dis 66:832–834PubMedCrossRefGoogle Scholar
  68. 68.
    Konstantopoulos K, Kanta A, Deltas C, Atamian V, Mavrogianni D, Tzioufas AG, Kollainis I, Ritis K, Moutsopoulos HM (2003) Familial Mediterranean fever associated pyrin mutations in Greece. Ann Rheum Dis 62:479–481PubMedCrossRefGoogle Scholar
  69. 69.
    La Regina M, Nucera G, Diaco M, Procopio A, Gasbarrini G, Notarnicola C, Kone-Paut I, Touitou I, Manna R (2003) Familial Mediterranean fever is no longer a rare disease in Italy. Eur J Hum Genet 11:50–56PubMedCrossRefGoogle Scholar
  70. 70.
    Lachmann HJ, Sengul B, Yavuzsen TU, Booth DR, Booth SE, Bybee A, Gallimore JR, Soyturk M, Akar S, Tunca M, Hawkins PN (2006) Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations. Rheumatology (Oxford) 45:746–750CrossRefGoogle Scholar
  71. 71.
    Langevitz P, Zemer D, Livneh A, Shemer J, Pras M (1994) Protracted febrile myalgia in patients with familial Mediterranean fever. J Rheumatol 21:1708–1709PubMedGoogle Scholar
  72. 72.
    Laxer RM, Shore AD, Manson D, King S, Silverman ED, Wilmot DM (1988) Chronic recurrent multifocal osteomyelitis and psoriasis–a report of a new association and review of related disorders. Semin Arthritis Rheum 17:260–270PubMedCrossRefGoogle Scholar
  73. 73.
    Leong SC, Karkos PD, Apostolidou MT (2006) Is there a role for the otolaryngologist in PFAPA syndrome? A systematic review. Int J Pediatr Otorhinolaryngol 70:1841–1845PubMedCrossRefGoogle Scholar
  74. 74.
    Lindor NM, Arsenault TM, Solomon H, Seidman CE, McEvoy MT (1997) A new autosomal dominant disorder of pyogenic sterile arthritis, pyoderma gangrenosum, and acne: PAPA syndrome. Mayo Clin Proc 72:611–615PubMedCrossRefGoogle Scholar
  75. 75.
    Livneh A, Langevitz P, Shinar Y, Zaks N, Kastner DL, Pras M, Pras E (1999) MEFV mutation analysis in patients suffering from amyloidosis of familial Mediterranean fever. Amyloid 6:1–6PubMedGoogle Scholar
  76. 76.
    Livneh A, Langevitz P, Zemer D, Zaks N, Kees S, Lidar T, Migdal A, Padeh S, Pras M (1997) Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 40:1879–1885PubMedCrossRefGoogle Scholar
  77. 77.
    Lobito AA, Kimberley FC, Muppidi JR, Komarow H, Jackson AJ, Hull KM, Kastner DL, Screaton GR, Siegel RM (2006) Abnormal disulfide-linked oligomerization results in ER retention and altered signaling by TNFR1 mutants in TNFR1-associated periodic fever syndrome (TRAPS). Blood 108:1320–1327PubMedCrossRefGoogle Scholar
  78. 78.
    Mandey SH, Schneiders MS, Koster J, Waterham HR (2006) Mutational spectrum and genotype-phenotype correlations in mevalonate kinase deficiency. Hum Mutat 27:796–802PubMedCrossRefGoogle Scholar
  79. 79.
    Marshall GS, Edwards KM, Butler J, Lawton AR (1987) Syndrome of periodic fever, pharyngitis, and aphthous stomatitis. J Pediatr 110:43–46PubMedCrossRefGoogle Scholar
  80. 80.
    Marshall GS, Edwards KM, Lawton AR (1989) PFAPA syndrome. Pediatr Infect Dis J 8:658–659PubMedGoogle Scholar
  81. 81.
    Martinon F, Tschopp J (2007) Inflammatory caspases and inflammasomes: master switches of inflammation. Cell Death Differ 14:10–22PubMedCrossRefGoogle Scholar
  82. 82.
    McDermott MF, Aksentijevich I, Galon J, McDermott EM, Ogunkolade BW, Centola M, Mansfield E, Gadina M, Karenko L, Pettersson T, McCarthy J, Frucht DM, Aringer M, Torosyan Y, Teppo AM, Wilson M, Karaarslan HM, Wan Y, Todd I, Wood G, Schlimgen R, Kumarajeewa TR, Cooper SM, Vella JP, Amos CI, Mulley J, Quane KA, Molloy MG, Ranki A, Powell RJ, Hitman GA, O’Shea JJ, Kastner DL (1999) Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell 97:133–144PubMedCrossRefGoogle Scholar
  83. 83.
    McDermott MF, Tschopp J (2007) From inflammasomes to fevers, crystals and hypertension: how basic research explains inflammatory diseases. Trends Mol Med 13: 381–388PubMedCrossRefGoogle Scholar
  84. 84.
    McGonagle D, McDermott MF (2006) A proposed classification of the immunological diseases. PLoS Med 3:e297PubMedCrossRefGoogle Scholar
  85. 85.
    Metyas SK, Hoffman HM (2006) Anakinra prevents symptoms of familial cold autoinflammatory syndrome and Raynaud’s disease. J Rheumatol 33:2085–2087PubMedGoogle Scholar
  86. 86.
    Miceli-Richard C, Lesage S, Rybojad M, Prieur AM, Manouvrier-Hanu S, Hafner R, Chamaillard M, Zouali H, Thomas G, Hugot JP (2001) CARD15 mutations in Blau syndrome. Nat Genet 29:19–20PubMedCrossRefGoogle Scholar
  87. 87.
    Miller JJ, 3rd (1986) Early-onset “sarcoidosis” and “familial granulomatous arthritis (arteritis)”: the same disease. J Pediatr 109:387–388PubMedCrossRefGoogle Scholar
  88. 88.
    Milman N, Andersen CB, Hansen A, van Overeem Hansen T, Nielsen FC, Fledelius H, Ahrens P, Nielsen OH (2006) Favourable effect of TNF-alpha inhibitor (infliximab) on Blau syndrome in monozygotic twins with a de novo CARD15 mutation. Apmis 114: 912–919PubMedCrossRefGoogle Scholar
  89. 89.
    Mirault T, Launay D, Cuisset L, Hachulla E, Lambert M, Queyrel V, Quemeneur T, Morell-Dubois S, Hatron PY (2006) Recovery from deafness in a patient with Muckle–Wells syndrome treated with anakinra. Arthritis Rheum 54:1697–1700PubMedCrossRefGoogle Scholar
  90. 90.
    Mor A, Pillinger MH, Kishimoto M, Abeles AM, Livneh A (2007) Familial Mediterranean fever successfully treated with etanercept. J Clin Rheumatol 13:38–40PubMedCrossRefGoogle Scholar
  91. 91.
    Muckle TW, M. (1962) Urticaria, deafness, and amyloidosis: a new heredo-familial syndrome. Q J Med 31: 235–248PubMedGoogle Scholar
  92. 92.
    Neven B, Callebaut I, Prieur AM, Feldmann J, Bodemer C, Lepore L, Derfalvi B, Benjaponpitak S, Vesely R, Sauvain MJ, Oertle S, Allen R, Morgan G, Borkhardt A, Hill C, Gardner-Medwin J, Fischer A, de Saint Basile G (2004) Molecular basis of the spectral expression of CIAS1 mutations associated with phagocytic cell-mediated autoinflammatory disorders CINCA/NOMID, MWS, and FCU. Blood 103:2809–2815PubMedCrossRefGoogle Scholar
  93. 93.
    Neven B, Valayannopoulos V, Quartier P, Blanche S, Prieur AM, Debre M, Rolland MO, Rabier D, Cuisset L, Cavazzana-Calvo M, de Lonlay P, Fischer A (2007) Allogeneic bone marrow transplantation in mevalonic aciduria. N Engl J Med 356:2700–2703PubMedCrossRefGoogle Scholar
  94. 94.
    Nevyjel M, Pontillo A, Calligaris L, Tommasini A, D’Osualdo A, Waterham HR, Granzotto M, Crovella S, Barbi E, Ventura A (2007) Diagnostics and therapeutic insights in a severe case of mevalonate kinase deficiency. Pediatrics 119:e523–527PubMedCrossRefGoogle Scholar
  95. 95.
    Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, Britton H, Moran T, Karaliuskas R, Duerr RH, Achkar JP, Brant SR, Bayless TM, Kirschner BS, Hanauer SB, Nunez G, Cho JH (2001) A frameshift mutation in NOD2 associated with susceptibility to Crohn’s disease. Nature 411:603–606PubMedCrossRefGoogle Scholar
  96. 96.
    Ozcakar ZB, Yalcinkaya F, Yuksel S, Acar B, Gokmen D, Ekim M (2006) Possible effect of subclinical inflammation on daily life in familial Mediterranean fever. Clin Rheumatol 25:149–152PubMedCrossRefGoogle Scholar
  97. 97.
    Padeh S (2005) Periodic fever syndromes. Pediatr Clin North Am 52:577–609, viiPubMedCrossRefGoogle Scholar
  98. 98.
    Padeh S, Brezniak N, Zemer D, Pras E, Livneh A, Langevitz P, Migdal A, Pras M, Passwell JH (1999) Periodic fever, aphthous stomatitis, pharyngitis, and adenopathy syndrome: clinical characteristics and outcome. J Pediatr 135:98–101PubMedCrossRefGoogle Scholar
  99. 99.
    Papin S, Cuenin S, Agostini L, Martinon F, Werner S, Beer HD, Grutter C, Grutter M, Tschopp J (2007) The SPRY domain of Pyrin, mutated in familial Mediterranean fever patients, interacts with inflammasome components and inhibits proIL-1beta processing. Cell Death Differ 14:1457–1466PubMedCrossRefGoogle Scholar
  100. 100.
    Parikh SR, Reiter ER, Kenna MA, Roberson D (2003) Utility of tonsillectomy in 2 patients with the syndrome of periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis. Arch Otolaryngol Head Neck Surg 129:670–673PubMedCrossRefGoogle Scholar
  101. 101.
    Pascual V, Allantaz F, Arce E, Punaro M, Banchereau J (2005) Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade. J Exp Med 201:1479–1486PubMedCrossRefGoogle Scholar
  102. 102.
    Pay S, Turkcapar N, Kalyoncu M, Simsek I, Beyan E, Ertenli I, Ozturk MA, Duzgun N, Erdem H, Ozbalkan Z, Kiraz S, Kinikli G, Besbas N, Dinc A, Ates A, Olmez U, Calguneri M, Aydintug OT, Bakkaloglu A, Turan M, Turgay M, Karaaslan Y, Topaloglu R, Duman M, Ozen S (2006) A multicenter study of patients with adult-onset Still’s disease compared with systemic juvenile idiopathic arthritis. Clin Rheumatol 25:639–644PubMedCrossRefGoogle Scholar
  103. 103.
    Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, He X, Maldonado-Cocco J, Orozco-Alcala J, Prieur AM, Suarez-Almazor ME, Woo P (2004) International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 31:390–392PubMedGoogle Scholar
  104. 104.
    Prieur AM, Griscelli C (1981) Arthropathy with rash, chronic meningitis, eye lesions, and mental retardation. J Pediatr 99:79–83PubMedCrossRefGoogle Scholar
  105. 105.
    Prieur AM, Griscelli C, Lampert F, Truckenbrodt H, Guggenheim MA, Lovell DJ, Pelkonnen P, Chevrant-Breton J, Ansell BM (1987) A chronic, infantile, neurological, cutaneous and articular (CINCA) syndrome. A specific entity analysed in 30 patients. Scand J Rheumatol Suppl 66:57–68PubMedCrossRefGoogle Scholar
  106. 106.
    Quaglietta L, te Velde A, Staiano A, Troncone R, Hommes DW (2007) Functional consequences of NOD2/CARD15 mutations in Crohn disease. J Pediatr Gastroenterol Nutr 44:529–539PubMedCrossRefGoogle Scholar
  107. 107.
    Radford-Smith G, Pandeya N (2006) Associations between NOD2/CARD15 genotype and phenotype in Crohn’s disease–Are we there yet? World J Gastroenterol 12:7097–7103PubMedGoogle Scholar
  108. 108.
    Ravet N, Rouaghe S, Dode C, Bienvenu J, Stirnemann J, Levy P, Delpech M, Grateau G (2006) Clinical significance of P46L and R92Q substitutions in the tumour necrosis factor superfamily 1A gene. Ann Rheum Dis 65:1158–1162PubMedCrossRefGoogle Scholar
  109. 109.
    Renn CN, Helmer A, Megahed M (2007) [Pyogenic arthritis, pyoderma gangrenosum and acne syndrome (PAPA syndrome)]. Hautarzt 58:383–384PubMedCrossRefGoogle Scholar
  110. 110.
    Rezaei N (2006) TNF-receptor-associated periodic syndrome (TRAPS): an autosomal dominant multisystem disorder. Clin Rheumatol 25:773–777PubMedCrossRefGoogle Scholar
  111. 111.
    Rose CD, Doyle TM, McIlvain-Simpson G, Coffman JE, Rosenbaum JT, Davey MP, Martin TM (2005) Blau syndrome mutation of CARD15/NOD2 in sporadic early onset granulomatous arthritis. J Rheumatol 32:373–375PubMedGoogle Scholar
  112. 112.
    Rose CD, Wouters CH, Meiorin S, Doyle TM, Davey MP, Rosenbaum JT, Martin TM (2006) Pediatric granulomatous arthritis: an international registry. Arthritis Rheum 54:3337–3344PubMedCrossRefGoogle Scholar
  113. 113.
    Rosenberg AM, Yee EH, MacKenzie JW (1983) Arthritis in childhood sarcoidosis. J Rheumatol 10:987–990PubMedGoogle Scholar
  114. 114.
    Saatci U, Ozen S, Ozdemir S, Bakkaloglu A, Besbas N, Topaloglu R, Arslan S (1997) Familial Mediterranean fever in children: report of a large series and discussion of the risk and prognostic factors of amyloidosis. Eur J Pediatr 156:619–623PubMedCrossRefGoogle Scholar
  115. 115.
    Sakallioglu O, Duzova A, Ozen S (2006) Etanercept in the treatment of arthritis in a patient with familial Mediterranean fever. Clin Exp Rheumatol 24:435–437PubMedGoogle Scholar
  116. 116.
    Schaffer JV, Chandra P, Keegan BR, Heller P, Shin HT (2007) Widespread granulomatous dermatitis of infancy: an early sign of Blau syndrome. Arch Dermatol 143:386–391PubMedCrossRefGoogle Scholar
  117. 117.
    Schultz C, Holterhus PM, Seidel A, Jonas S, Barthel M, Kruse K, Bucsky P (1999) Chronic recurrent multifocal osteomyelitis in children. Pediatr Infect Dis J 18:1008–1013PubMedCrossRefGoogle Scholar
  118. 118.
    Shetty AK, Gedalia A (1998) Sarcoidosis: a pediatric perspective. Clin Pediatr (Phila) 37:707–717CrossRefGoogle Scholar
  119. 119.
    Shoham NG, Centola M, Mansfield E, Hull KM, Wood G, Wise CA, Kastner DL (2003) Pyrin binds the PSTPIP1/CD2BP1 protein, defining familial Mediterranean fever and PAPA syndrome as disorders in the same pathway. Proc Natl Acad Sci USA 100:13501–13506PubMedCrossRefGoogle Scholar
  120. 120.
    Siegal S (1945) Benign paroxysmal peritonitis. Ann Intern Med 23:1–21Google Scholar
  121. 121.
    Simon A, Bodar EJ, van der Hilst JC, van der Meer JW, Fiselier TJ, Cuppen MP, Drenth JP (2004) Beneficial response to interleukin 1 receptor antagonist in traps. Am J Med 117:208–210PubMedCrossRefGoogle Scholar
  122. 122.
    Simon A, Drewe E, van der Meer JW, Powell RJ, Kelley RI, Stalenhoef AF, Drenth JP (2004) Simvastatin treatment for inflammatory attacks of the hyperimmunoglobulinemia D and periodic fever syndrome. Clin Pharmacol Ther 75:476–483PubMedCrossRefGoogle Scholar
  123. 123.
    Simon A, van der Meer JW, Vesely R, Myrdal U, Yoshimura K, Duys P, Drenth JP (2006) Approach to genetic analysis in the diagnosis of hereditary autoinflammatory syndromes. Rheumatology (Oxford) 45:269–273CrossRefGoogle Scholar
  124. 124.
    Stichweh DS, Punaro M, Pascual V (2005) Dramatic improvement of pyoderma gangrenosum with infliximab in a patient with PAPA syndrome. Pediatr Dermatol 22:262–265PubMedCrossRefGoogle Scholar
  125. 125.
    Stojanov S, Hoffmann F, Kery A, Renner ED, Hartl D, Lohse P, Huss K, Fraunberger P, Malley JD, Zellerer S, Albert MH, Belohradsky BH (2006) Cytokine profile in PFAPA syndrome suggests continuous inflammation and reduced anti-inflammatory response. Eur Cytokine Netw 17:90–97PubMedGoogle Scholar
  126. 126.
    Tallon B, Corkill M (2006) Peculiarities of PAPA syndrome. Rheumatology (Oxford) 45:1140–1143CrossRefGoogle Scholar
  127. 127.
    Tasher D, Somekh E, Dalal I (2006) PFAPA syndrome: new clinical aspects disclosed. Arch Dis Child 91:981–984PubMedCrossRefGoogle Scholar
  128. 128.
    Thomas KT, Feder HM, Jr., Lawton AR, Edwards KM (1999) Periodic fever syndrome in children. J Pediatr 135:15–21PubMedCrossRefGoogle Scholar
  129. 129.
    Ting JP, Kastner DL, Hoffman HM (2006) CATERPILLERs, pyrin and hereditary immunological disorders. Nat Rev Immunol 6:183–195PubMedCrossRefGoogle Scholar
  130. 130.
    Touitou I, Magne X, Molinari N, Navarro A, Quellec AL, Picco P, Seri M, Ozen S, Bakkaloglu A, Karaduman A, Garnier JM, Demaille J, Kone-Paut I (2000) MEFV mutations in Behcet’s disease. Hum Mutat 16:271–272PubMedCrossRefGoogle Scholar
  131. 131.
    Touitou I, Sarkisian T, Medlej-Hashim M, Tunca M, Livneh A, Cattan D, Yalcinkaya F, Ozen S, Majeed H, Ozdogan H, Kastner D, Booth D, Ben-Chetrit E, Pugnere D, Michelon C, Seguret F, Gershoni-Baruch R (2007) Country as the primary risk factor for renal amyloidosis in familial Mediterranean fever. Arthritis Rheum 56:1706–1712PubMedCrossRefGoogle Scholar
  132. 132.
    Tunca M, Akar S, Onen F, Ozdogan H, Kasapcopur O, Yalcinkaya F, Tutar E, Ozen S, Topaloglu R, Yilmaz E, Arici M, Bakkaloglu A, Besbas N, Akpolat T, Dinc A, Erken E (2005) Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study. Medicine (Baltimore) 84:1–11CrossRefGoogle Scholar
  133. 133.
    Tunca M, Kirkali G, Soyturk M, Akar S, Pepys MB, Hawkins PN (1999) Acute phase response and evolution of familial Mediterranean fever. Lancet 353:1415PubMedCrossRefGoogle Scholar
  134. 134.
    van der Meer JW, Vossen JM, Radl J, van Nieuwkoop JA, Meyer CJ, Lobatto S, van Furth R (1984) Hyperimmunoglobulinaemia D and periodic fever: a new syndrome. Lancet 1:1087–1090PubMedGoogle Scholar
  135. 135.
    Verbsky JW, White AJ (2004) Effective use of the recombinant interleukin 1 receptor antagonist anakinra in therapy resistant systemic onset juvenile rheumatoid arthritis. J Rheumatol 31:2071–2075PubMedGoogle Scholar
  136. 136.
    Wang X, Kuivaniemi H, Bonavita G, Mutkus L, Mau U, Blau E, Inohara N, Nunez G, Tromp G, Williams CJ (2002) CARD15 mutations in familial granulomatosis syndromes: a study of the original Blau syndrome kindred and other families with large-vessel arteritis and cranial neuropathy. Arthritis Rheum 46:3041–3045PubMedCrossRefGoogle Scholar
  137. 137.
    Williamson LM, Hull D, Mehta R, Reeves WG, Robinson BH, Toghill PJ (1982) Familial Hibernian fever. Q J Med 51:469–480PubMedGoogle Scholar
  138. 138.
    Wise CA, Bennett LB, Pascual V, Gillum JD, Bowcock AM (2000) Localization of a gene for familial recurrent arthritis. Arthritis Rheum 43:2041–2045PubMedCrossRefGoogle Scholar
  139. 139.
    Wise CA, Gillum JD, Seidman CE, Lindor NM, Veile R, Bashiardes S, Lovett M (2002) Mutations in CD2BP1 disrupt binding to PTP PEST and are responsible for PAPA syndrome, an autoinflammatory disorder. Hum Mol Genet 11:961–969PubMedCrossRefGoogle Scholar
  140. 140.
    Yamaguchi M, Ohta A, Tsunematsu T, Kasukawa R, Mizushima Y, Kashiwagi H, Kashiwazaki S, Tanimoto K, Matsumoto Y, Ota T, et al. (1992) Preliminary criteria for classification of adult Still’s disease. J Rheumatol 19:424–430PubMedGoogle Scholar
  141. 141.
    Yeon HB, Lindor NM, Seidman JG, Seidman CE (2000) Pyogenic arthritis, pyoderma gangrenosum, and acne syndrome maps to chromosome 15q. Am J Hum Genet 66:1443–1448PubMedCrossRefGoogle Scholar
  142. 142.
    Yilmaz E, Balci B, Kutlay S, Ozen S, Erturk S, Oner A, Besbas N, Bakkaloglu A (2003) Analysis of the modifying effects of SAA1, SAA2 and TNF-alpha gene polymorphisms on development of amyloidosis in FMF patients. Turk J Pediatr 45:198–202PubMedGoogle Scholar
  143. 143.
    Yu JW, Wu J, Zhang Z, Datta P, Ibrahimi I, Taniguchi S, Sagara J, Fernandes-Alnemri T, Alnemri ES (2006) Cryopyrin and pyrin activate caspase-1, but not NF-kappaB, via ASC oligomerization. Cell Death Differ 13:236–249PubMedCrossRefGoogle Scholar
  144. 144.
    Zemer D, Revach M, Pras M, Modan B, Schor S, Sohar E, Gafni J (1974) A controlled trial of colchicine in preventing attacks of familial mediterranean fever. N Engl J Med 291:932–934PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2008

Authors and Affiliations

  • Stefan Berg
    • 1
  • Anders Fasth
    • 1
  1. 1.Department of PediatricsGöteborg University The Queen Silvia Children’s HospitalGöteborgSweden

Personalised recommendations